Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy
Martin Lubin, Adam Lubin · 2009
Read Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy by Martin Lubin, Adam Lubin (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005735.txt.
Description
Martin Lubin and Adam Lubin proposed in 2009 a way to kill only those tumor cells that lack a certain enzyme. The enzyme, MTAP, sits near a famous tumor guard gene on chromosome 9. Both genes are often deleted together in lung and pancreas cancers, brain tumors, and bone cancers.
Cells without MTAP depend on backup routes that normal cells can do without. The authors lay out a strategy that exploits that dependence to strike the tumor and spare healthy tissue. Such selective killing is the goal of modern cancer drug design. The paper maps the logic and the cancers where it could apply.
Catalog record
| CREATOR | Martin Lubin, Adam Lubin |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005735